Use of a left ventricular assist device in hypertrophic cardiomyopathy.
Late stages of hypertrophic cardiomyopathy (HCM) result in medically refractory heart failure. Current treatments include septal myomectomy or alcohol ablation; however, not all patients are eligible for these procedures. We describe the technical aspects of implantation of a HeartMate II left ventricular assist device as a bridge to transplant therapy for a patient with HCM and end-stage heart failure. Pre- and post-operative imaging demonstrates the importance of establishing a functional inflow tract for the device.
School of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Elisabeth
E
Wynne
James D
JD
Bergin
Gorav
G
Ailawadi
John A
JA
Kern
Jamie L W
JL
Kennedy
D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000601:surgery*; D017548:Echocardiography, Transesophageal; D004867:Equipment Design; D005260:Female; D005500:Follow-Up Studies; D006352:Heart Ventricles / Q000601:surgery*; D006353:Heart-Assist Devices; D006801:Humans; D008875:Middle Aged; D014057:Tomography, X-Ray Computed